T H Chou
Overview
Explore the profile of T H Chou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
130
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
LeBlanc K, Misra D, Zacherl J, Petrella G, Khan F, Negro P, et al.
Hernia
. 2015 Nov;
19 Suppl 1:S127-31.
PMID: 26518788
No abstract available.
2.
Redman B, Chou T, Zalupski M, Uberti J, Flaherty L, Dan M, et al.
J Immunother Emphasis Tumor Immunol
. 1995 Aug;
18(2):115-8.
PMID: 8574466
Previous reports of autologous bone marrow transplant (auto-BMT) have demonstrated that myeloablative therapy followed by cyclosporin A (CsA), with and without interferon (IFN), can generate autoreactive cytotoxic T lymphocytes (auto-CTL)...
3.
Abubakr Y, Chou T, Redman B
J Urol
. 1994 Jul;
152(1):156-7.
PMID: 8201650
Spontaneous remission of renal cell carcinoma is a rare occurrence for which immunological factors have been implicated as a possible mechanism. We report a case of spontaneous remission of metastatic...
4.
Chen B, Chou T, SENSENBRENNER L
Exp Hematol
. 1993 Nov;
21(12):1591-6.
PMID: 8405240
Peritoneal injection of thioglycollate medium (TM) to mice results in a dramatic increase in total number of peritoneal macrophages within 48 to 72 hours. Unlike resident macrophages, a fraction (10...
5.
Ueda M, Joshi I, Dan M, Uberti J, Chou T, SENSENBRENNER L, et al.
Transplantation
. 1993 Aug;
56(2):351-6.
PMID: 8356589
In order to obtain T cells for adoptive immunotherapy after autologous bone marrow transplantation (ABMT) for patients with resistant hematological malignancies, a culture system was developed for growing T cells...
6.
Chen B, Chou T, SENSENBRENNER L
Exp Hematol
. 1993 May;
21(5):623-8.
PMID: 8513862
Murine peritoneal exudate macrophages (PEM) co-express granulocyte-macrophage colony-stimulating factor (GM-CSF) and macrophage CSF (M-CSF) receptors, among others. Treatment of PEM with lipopolysaccharide (LPS) or tumor-promoting phorbol ester (12-O-tetradecanoylphorbol-13-acetate [TPA]) induces...
7.
Redman B, Flaherty L, Chou T, Kraut M, Martino S, Simon M, et al.
J Immunother (1991)
. 1992 Jul;
12(1):50-4.
PMID: 1637782
Fourteen patients were entered into a phase I dose-escalation trial of macrophage colony-stimulating factor (M-CSF). M-CSF was administered to inpatients by rapid 15 min i.v. infusion every 8 h x...
8.
Uberti J, Martilotti F, Chou T, Kaplan J
Blood
. 1992 Jan;
79(1):261-8.
PMID: 1370206
We have found that murine lymphokine activated killer (LAK) cells have veto and natural suppressor activities in vitro, and prevent graft-versus-host disease (GVHD) in vivo. To determine whether human LAK...
9.
Redman B, Flaherty L, Chou T, Nakeff A, Pillote K, Kaplan J
J Immunother (1991)
. 1991 Apr;
10(2):147-51.
PMID: 2043595
Thirteen previously untreated patients with metastatic melanoma entered into a phase II chemo-immunotherapy trial were monitored immunologically during treatment. Treatment consisted of dacarbazine (DTIC) 750 mg/m2 and cisplatin 100 mg/m2...
10.
Redman B, Flaherty L, Chou T, Al-Katib A, Kraut M, Martino S, et al.
J Clin Oncol
. 1990 Jul;
8(7):1269-76.
PMID: 2113571
Twenty-six patients with metastatic cancer were entered into a phase I trial of concurrent recombinant interleukin-2 (IL-2) and recombinant interferon-gamma (IFN-gamma). IL-2 was administered as a continuous intravenous infusion for...